Familial Hypercholesterolemia.

Familial hypercholesterolemia affects both homozygous and heterozygous individuals, requiring tailored assessment, diagnosis, and management strategies.

• Why it matters: Early detection and effective treatment are crucial to prevent cardiovascular disease in individuals with FH, yet gaps remain in diagnosis and management practices.
• What they did: The article reviews methods for assessing and diagnosing FH and discusses treatment options for both homozygous and heterozygous forms, emphasizing clinical approaches.
• The result: Enhanced understanding of FH management can improve patient outcomes by enabling timely diagnosis and personalized treatment plans.